IMR Press / RCM / Volume 20 / Issue 1 / DOI: 10.31083/j.rcm.2019.01.3189
Open Access Review
Advances in epigenetic regulation of vascular aging
Show Less
1 Department of Internal Medicine-Cardiovascular, The second hospital of Dalian medical university, Liaoning, 116027, China
2 Department of Medical Affair, The second hospital of Dalian medical university, Dalian City, Liaoning, 116027, China
*Correspondence: (Yufeng Liu)
Rev. Cardiovasc. Med. 2019, 20(1), 19–25;
Published: 30 March 2019
Copyright: © 2019 Jin et al. Published by IMR Press.
This is an open access article under the CC BY-NC 4.0 license (

Vascular aging is a major risk factor and driver of agerelated cardiovascular diseases (CVD). Atherosclerosis, hypertension, and other CVD lead to vascular dysfunction that involves multiple pathological processes such as oxidative stress, endothelial dysfunction, inflammation, and autophagy. Epigenetics refers to genetic changes that occur when the DNA remains unchanged that include DNA methylation, histone modification, and non-coding RNA. It has been reported that epigenetics plays an effective regulatory role in CVD and affects cardiovascular repair function. Presently, drugs targeting epigenetics have applications in malignant tumors and inflammation. Therefore, exploration of epigenetic mechanisms in vascular aging will allow us to understand the pathogenesis of diseases related to vascular aging. This review focuses on the pathological changes in vascular aging and analyzes the relationship between vascular aging and epigenetics. Additionally, this review focuses on the pathogenesis of vascular aging related diseases from a new perspective in order to develop epigenetic-based treatment strategies for patients with age-related cardiovascular diseases.

Vascular aging
endothelial dysfunction
oxidative stress
Figure 1.
Back to top